Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (32)

2024

  1. An in vivo drug screen in zebrafish reveals that cyclooxygenase 2-derived prostaglandin D2 promotes spinal cord neurogenesis

    Cell Proliferation, Vol. 57, Núm. 5

  2. Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101

    International Journal of Molecular Sciences

  3. Comparative analysis of multidrug-resistant Klebsiella pneumoniae strains of food and human origin reveals overlapping populations

    International Journal of Food Microbiology, Vol. 413

  4. Draft genome sequence of Klebsiella pneumoniae KLEB-33: a convergent biofilm hyperforming multiresistant strain belonging to the emerging ST16 lineage harboring multiple hypervirulence genes

    Microbiology Resource Announcements, Vol. 13, Núm. 4

  5. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins

    Allergy: European Journal of Allergy and Clinical Immunology

  6. Isothermal calorimetry reveals that successful regeneration after a spinal cord injury in larval zebrafish is associated with an increase in energy expenditure

    Biochimica et Biophysica Acta - Bioenergetics, Vol. 1865, Núm. 4

  7. Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response

    Journal of Infection and Public Health, Vol. 17, Núm. 4, pp. 588-600

  8. Proteomic analysis of post-COVID condition: Insights from plasma and pellet blood fractions

    Journal of Infection and Public Health, Vol. 17, Núm. 12

  9. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  10. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy

    Cancers, Vol. 16, Núm. 13

  11. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666